US Stock MarketDetailed Quotes

FHTX Foghorn Therapeutics

Watchlist
  • 4.060
  • -0.320-7.31%
Close Jan 24 16:00 ET
  • 4.080
  • +0.020+0.49%
Post 20:01 ET
225.71MMarket Cap-2.19P/E (TTM)

About Foghorn Therapeutics Company

Foghorn Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is discovering and developing a novel class of precision medicine therapeutics targeting the chromatin regulatory system in oncology. Through its scalable Gene Traffic Control product platform, the firm is systematically interrogating and drugging the chromatin regulatory system. The company was founded by Cigall Kadoch, Gerald W. Crabtree and Douglas G. Cole in October 2015 and is headquartered in Cambridge, MA.

Company Profile

SymbolFHTX
Company NameFoghorn Therapeutics
Listing DateOct 23, 2020
Issue Price16.00
Founded2015
CEOMr. Adrian Gottschalk
MarketNASDAQ
Employees116
Fiscal Year Ends12-31
Address500 Technology Square,Suite 700
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139
Phone1-617-586-3100
Websitehttp://www.foghorntx.com

Company Executives

  • Name
  • Position
  • Salary
  • Adrian Gottschalk
  • Chief Executive Officer and Director
  • 2.50M
  • Carlos Costa
  • Chief People Officer
  • --
  • Fanny Cavalie
  • Chief Strategy and Business Operations Officer
  • --
  • Dr. Alfonso Quintas-Cardama
  • Chief Medical Officer
  • 1.84M
  • Michael J. LaCascia
  • Chief Legal Officer
  • --
  • Dr. Steven F. Bellon, PhD
  • Chief Scientific Officer
  • 1.19M
  • Kristian F. Humer
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Douglas G. Cole, M.D.
  • Chairman of the Board
  • 184.57K
  • Dr. Thomas J. Lynch
  • Independent Director
  • 145.57K
  • B. Lynne Parshall, Esq.,J.D.
  • Independent Director
  • 157.65K
  • Ian F. Smith
  • Independent Director
  • 141.57K
  • Dr. Scott Biller, PhD
  • Independent Director
  • 145.57K
  • Dr. Michael Mendelsohn, M.D.
  • Independent Director
  • 154.57K
  • Dr. Balkrishan Gill, PhD
  • Independent Director
  • 159.07K
  • Stephen J. DiPalma
  • Treasurer
  • --

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
GVS
870976
+29.98%
Hangzhou CNCR-IT
300250
+20.03%
Shanghai Newtouch Software
688590
+20.01%
4
Ucap Cloud Information Technology Co.,Ltd
688228
+20.00%
5
Yangtze Optical Electronic
688143
+20.00%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
U.S.-China talks spark interest, no more inflation?
🎙️Discussion: 1. How will Trump's China policies affect Chinese assets? 2. Which sectors might benefit as U.S. inflation risks decline? Show More
China Will Adopt a "Moderately Accommodative" Monetary Policy in the Next Year, The First Shift to Easing Since 2011
Earnings Season Underway
Earnings season is here. What to know?